Skip to main content
Clinical Trials/CTRI/2018/01/011256
CTRI/2018/01/011256
Completed
Phase 4

Evaluation of clinical efficacy and safety of capsule Diacea in the management of Diabetes Mellitus type-2[Madhumeha]

MB LIFESCIENCES PVT LTD0 sites50 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
MB LIFESCIENCES PVT LTD
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 4, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
MB LIFESCIENCES PVT LTD

Eligibility Criteria

Inclusion Criteria

  • 1\. newly diagnosed cases of Diabetes Mellitus
  • 2\. Known cases of Diabetes Mellitus with uncontrolled blood sugar with their current medicine.

Exclusion Criteria

  • 1\. patient having complication of Diabetes Mellitus
  • 2\. patient suffering from brittle diabetes
  • 3\. patient with past history of IHD, MI, CVA
  • 4\. patient with poorly controlled Hypertension that is 160/100 mm / Hg
  • 5\. Patient with serious systemic diseases
  • 6\. Pregnant lady / Lactating mother / gestational Diabetes patient
  • 7\. Patient who are taking steroids, OC pills, on Hormone Replacement Therapy
  • 8\. patient with hypersensitivity to any ingredients of trial drug

Outcomes

Primary Outcomes

Not specified

Similar Trials